When the smoke cleared, BioNTech's shares closed the day more than 6% lower. The Food and Drug Administration (FDA), a ...

U.S. stocks were lower for a second straight session on Tuesday as comments from U.S. President Donald Trump and Treasury ...

WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, ...

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...

Vinay Prasad will serve as director of the FDA's Center for Biologics Evaluation and Research, which oversees vaccine and ...

Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter ...

WASHINGTON — Ever since President Trump announced he was slapping hefty tariffs on countries across the globe, he has been predicting they would force trading partners to sign major deals beneficial ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

The stock market suggested on Tuesday that, after some terrific gains in recent weeks, it needs more time to cool off. The Nasdaq composite fell nearly 0.9% to 17,689. As a daily chart shows, the tech ...

A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...

TRADING DAY Making sense of the forces driving global markets By Jamie McGeever, Markets Columnist Deep uncertainty, thin ...